Frédéric Chibon

6.8k total citations
117 papers, 4.3k citations indexed

About

Frédéric Chibon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Frédéric Chibon has authored 117 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 43 papers in Oncology and 30 papers in Cancer Research. Recurrent topics in Frédéric Chibon's work include Sarcoma Diagnosis and Treatment (76 papers), Cancer Genomics and Diagnostics (21 papers) and Cardiac tumors and thrombi (21 papers). Frédéric Chibon is often cited by papers focused on Sarcoma Diagnosis and Treatment (76 papers), Cancer Genomics and Diagnostics (21 papers) and Cardiac tumors and thrombi (21 papers). Frédéric Chibon collaborates with scholars based in France, United States and Italy. Frédéric Chibon's co-authors include Jean‐Michel Coindre, Gaëlle Pérot, Alain Aurias, Philippe Terrier, Pauline Lagarde, Agnès Neuville, Isabelle Hostein, Louis Guillou, Antoîne Italiano and Sabrina Croce and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Frédéric Chibon

112 papers receiving 4.2k citations

Peers

Countries citing papers authored by Frédéric Chibon

Since Specialization

Citations

This map shows the geographic impact of Frédéric Chibon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Chibon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Chibon more than expected).

Fields of papers citing papers by Frédéric Chibon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Chibon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Chibon. The network helps show where Frédéric Chibon may publish in the future.

Co-authorship network of co-authors of Frédéric Chibon

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Chibon. A scholar is included among the top collaborators of Frédéric Chibon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Chibon. Frédéric Chibon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	82P Advancing precision oncology in soft tissue sarcomas: The role of iTRAC in metastatic risk stratification and treatment personalization 2025 ·ESMO Open ·Frédéric Chibon, (unknown), Gaëlle Pérot, Philippe Rochaix, Thibaud Valentin, Gwénaël Ferron	0
2	CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS) 2025 ·Clinical Cancer Research ·Dario Callegaro, (unknown), Felix Boakye Oppong, Axelle Nzokirantevye, Saskia Litière, (unknown), (unknown), Loris De Cecco, Frédéric Chibon, Silvia Brich, Alessia Bertolotti, Paola Collini, Anna Maria Frezza, Paul H. Huang, Rick L. Haas, Sylvie Bonvalot, Winan J. van Houdt, Rosalba Miceli, Sandro Pasquali, Alessandro Gronchi	0
3	Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment 2023 ·Cancers ·Xiaolan Feng, Laurie Tonon, Haocheng Li, Élodie Darbo, Erin Pleasance, Nicolas Macagno, Armelle Dufresne, Mehdi Brahmi, Julien Bollard, Françoise Ducimetière, Marie Karanian, Alexandra Meurgey, Gaëlle Pérot, Thibaud Valentin, Frédéric Chibon, Jean‐Yves Blay	6
4	The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity 2023 ·NAR Cancer ·(unknown), (unknown), Genı́s Parra, (unknown), (unknown), Frédéric Chibon, Fréderic Escudié, Janick Sèlves, Jean‐Sèbastien Hoffmann, Rosine Guimbaud, Malik Lutzmann	2
5	ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas 2021 ·Cancers ·(unknown), Gaëlle Pérot, (unknown), Sophie Le Guellec, Nelly Desplat, (unknown), Lucile Delespaul, Tom Lesluyes, Élodie Darbo, Anne Gomez‐Brouchet, Élodie Richard, Jessica Baud, (unknown), Jean‐Michel Coindre, Jean‐Yves Blay, Frédéric Chibon	9
6	A Global and Integrated Analysis of CINSARC-Associated Genetic Defects 2020 ·Cancer Research ·Tom Lesluyes, Frédéric Chibon	11
7	Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma 2020 ·Science Translational Medicine ·Madi Y. Cissé, (unknown), Nelly Firmin, (unknown), Maud Heuillet, Floriant Bellvert, (unknown), (unknown), Romain Riscal, Giuseppe Arena, Frédéric Chibon, (unknown), Aurélie Maran-Gonzalez, Marie‐Christine Chateau, Charles Theillet, Sébastien Carrère, Jean‐Charles Portais, Laurent Le Cam, Laëtitia K. Linares	29
8	Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma 2020 ·OncoImmunology ·(unknown), Tom Lesluyes, Christine Ménétrier‐Caux, Mehdi Brahmi, Élodie Darbo, Maud Toulmonde, Antoîne Italiano, Olivier Mir, A. Le Cesne, Sophie Le Guellec, Thibaud Valentin, Christine Chevreau, Sylvie Bonvalot, Y Robin, Coindre Jm, Christophe Caux, Jean‐Yves Blay, Frédéric Chibon	30
9	Biologie et voies de signalisations impliquées dans l’oncogenèse des tumeurs desmoïdes 2020 ·Bulletin du Cancer ·Sébastien Salas, Frédéric Chibon	2
10	The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas 2019 ·Clinical Cancer Research ·Sabrina Croce, Tom Lesluyes, Carine Valle, Loubna Mhamdi, (unknown), Gaëlle Pérot, Eberhard Stoeckle, Jean‐Christophe Noël, (unknown), Mojgan Devouassoux‐Shisheboran, Denis Querleu, Frédéric Guyon, Anne Floquet, Camille Chakiba, Laétitia Mayeur, (unknown), Gaëtan MacGrogan, Isabelle Soubeyran, Sophie Le Guellec, Frédéric Chibon	15
11	Recurrent DMD Deletions Highlight Specific Role of Dp71 Isoform in Soft-Tissue Sarcomas 2019 ·Cancers ·(unknown), Vanessa Delcroix, Tom Lesluyes, Gaëlle Pérot, Pauline Lagarde, Lydia Lartigue, Jean‐Yves Blay, Frédéric Chibon	13
12	RCBTB1 Deletion Is Associated with Metastatic Outcome and Contributes to Docetaxel Resistance in Nontranslocation-Related Pleomorphic Sarcomas 2019 ·Cancers ·(unknown), Céline Brulard, Tom Lesluyes, Vanessa Delcroix, Gaëlle Pérot, (unknown), Mickaël Michaud, Jessica Baud, Pauline Lagarde, Alain Aurias, Jean‐Michel Coindre, Lydia Lartigue, Jean‐Yves Blay, Frédéric Chibon	4
13	Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience 2018 ·Cancer Medicine ·Daniel Orbach, Véronique Mosseri, Daniel Pissaloux, Gaëlle Pierron, Bernadette Brennan, Andrea Ferrari, Frédéric Chibon, Gianni Bisogno, Gian Luca De Salvo, Camille Chakiba, Nadège Corradini, Véronique Minard‐Colin, Anna Kelsey, Dominique Ranchère‐Vince	19
14	Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations 2018 ·European Journal of Surgical Oncology ·Milea J. M. Timbergen, M. Janssen, Cornelis Verhoef, Dirk J. Grünhagen, Frédéric Chibon, Marcel Smid, Stefan Sleijfer, Erik A.C. Wiemer	4
15	Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements 2017 ·Cell Cycle ·(unknown), Hélène Dumay‐Odelot, (unknown), Nicolas J. Tourasse, Delphine Allard, Fabrice André, Françoise Macari, Armelle Choquet, Pauline Lagarde, Guillaume Drutel, Thierry Lesté-Lasserre, (unknown), Tom Lesluyes, (unknown), Jean‐William Dupuy, Frédéric Chibon, Robert G. Roeder, Dominique Joubert, Stéphan Vagner, Martin Teichmann	18
16	Adult desmoid tumors: biology, management and ongoing trials 2017 ·Current Opinion in Oncology ·Nicolas Penel, Frédéric Chibon, Sébastien Salas	91
17	Recurrent TRIO Fusion in Nontranslocation–Related Sarcomas 2016 ·Clinical Cancer Research ·Lucile Delespaul, Tom Lesluyes, Gaëlle Pérot, Céline Brulard, Lydia Lartigue, Jessica Baud, Pauline Lagarde, Sophie Le Guellec, Agnès Neuville, Philippe Terrier, Dominique Vince-Ranchère, Susanne Schmidt, Anne Debant, Jean‐Michel Coindre, Frédéric Chibon	31
18	Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study 2016 ·The Lancet Oncology ·Antoîne Italiano, (unknown), (unknown), Gaëlle Pierron, Nathalie Auger, Laurent Alberti, Frédéric Chibon, Fabienne Escande, Anne‐Claire Voegeli, Jean‐Pierre Ghnassia, Frédérique Keslair, Marick Laé, Dominique Ranchère‐Vince, Philippe Terrier, Sandrine Baffert, Jean‐Michel Coindre, Florence Pédeutour	118
19	Mitotic Checkpoints and Chromosome Instability Are Strong Predictors of Clinical Outcome in Gastrointestinal Stromal Tumors 2011 ·Clinical Cancer Research ·Pauline Lagarde, Gaëlle Pérot, Audrey Kauffmann, Céline Brulard, (unknown), Isabelle Hostein, Agnès Neuville, Agnieszka Woźniak, Raf Sciot, Patrick Schöffski, Alain Aurias, Jean‐Michel Coindre, Maria Dêbiec‐Rychter, Frédéric Chibon	102
20	Constant p53 Pathway Inactivation in a Large Series of Soft Tissue Sarcomas with Complex Genetics 2010 ·American Journal Of Pathology ·Gaëlle Pérot, Frédéric Chibon, (unknown), Pauline Lagarde, Hugues de Thé, Philippe Terrier, Louis Guillou, Dominique Ranchère, Jean‐Michel Coindre, Alain Aurias	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact